Holen Sie sich die Stockscreener-App
1.98
0.51%
0.01
Handel nachbörslich:
2.01
0.03
+1.52%
Schlusskurs vom Vortag:
$1.97
Offen:
$1.98
24-Stunden-Volumen:
1.15M
Relative Volume:
0.53
Marktkapitalisierung:
$137.78M
Einnahmen:
$151.64M
Nettoeinkommen (Verlust:
$-37.23M
KGV:
-3.6237
EPS:
-0.5464
Netto-Cashflow:
$-13.58M
1W Leistung:
+14.45%
1M Leistung:
+52.31%
6M Leistung:
-5.26%
1J Leistung:
-54.90%
1-Tages-Spanne:
$1.9103
$2.095
1-Wochen-Bereich:
$1.69
$2.095
52-Wochen-Spanne:
$0.80
$4.8495
Neuronetics Inc Stock (STIM) Company Profile
Firmenname
Neuronetics Inc
Sektor
Branche
Telefon
877-600-7555
Adresse
3222 PHOENIXVILLE PIKE, MALVERN, PA
Compare STIM vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
STIM
Neuronetics Inc
|
1.98 | 125.95M | 151.64M | -37.23M | -13.58M | -0.5464 |
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Neuronetics Inc Stock (STIM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-13 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-10-13 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-10-13 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-01-22 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2020-02-06 | Eingeleitet | BTIG Research | Buy |
| 2018-07-24 | Eingeleitet | Canaccord Genuity | Buy |
Alle ansehen
Neuronetics Inc Aktie (STIM) Neueste Nachrichten
Neuronetics Opens Greenbrook Mental Wellness Centers National Center of Excellence in Rockville, Maryland - Quiver Quantitative
Greenbrook Opens National Center of Excellence for Advanced Interventional Psychiatry in Rockville, Maryland - The Manila Times
Rockville Center Will Pilot Emerging Treatments Before Rollout - Stock Titan
Neuronetics to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call - marketscreener.com
Neuronetics schedules an Aug. 11 webcast for Q2 results - Stock Titan
Neuronetics Inc (STIM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
STIM|Neuronetics Inc|Price:1.805|Chg%:+0.075 - TradingKey
Neuronetics Inc (STIM) Institutional Confidence - TradingKey
Neuronetics Inc (STIM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Neuronetics Inc (STIM) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Neuronetics, Inc. (STIM) stock price, news, quote and history - Yahoo Finance Australia
STIM|Neuronetics Inc|Price:1.730|Chg%:-0.150 - TradingKey
Neuronetics Inc (STIM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Neuronetics Inc (STIM) Cash Flow - TradingKey
TradingKey - TradingKey
Neuronetics, Inc. (STIM) Stock Price, News, Quote & History - Yahoo! Finance Canada
Neuronetics, Inc. Revenue Breakdown – NASDAQ:STIM - TradingView
What Does Jorey Chernett's Recent Buying Spree Signal for Neuronetics (STIM) - Kavout | AI
Neuronetics Inc (STIM) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Neuronetics (STIM) grants 500,000 RSUs to EVP and CFO Naor Nir - Stock Titan
Neuronetics EVP, CFO Naor Nir files initial beneficial ownership statement - Bitget
ETFs Investing in Neuronetics, Inc. Stocks - TradingView
Citizens reiterates Neuronetics stock rating on new CFO appointment By Investing.com - Investing.com Nigeria
Neuronetics names Nir Naor CFO - Medical Buyer
Citizens reiterates Neuronetics stock rating on new CFO appointment - Investing.com
Neuronetics appoints new CFO - MSN
symbol__ Stock Quote Price and Forecast - CNN
Neuronetics Names Nir Naor as CFO - Moomoo
Neuronetics Appoints Naor as CFO - Moomoo
Press Release: Neuronetics Appoints Nir Naor Chief Financial Officer; Announces Additional Management Changes - Moomoo
Neuronetics names Nir Naor as CFO, promotes Anderson to EVP By Investing.com - Investing.com Nigeria
Neuronetics names Nir Naor as CFO, promotes Anderson to EVP - Investing.com
Neuronetics Appoints Nir Naor Chief Financial Officer; Announces Additional Management Changes - The Manila Times
Neuronetics appoints Nir Naor as EVP, CFO and Treasurer; W. Andrew Macan to depart - TradingView
Neuronetics, Inc. Announces Management Changes - marketscreener.com
Neuronetics: Nir Naor Appointed Chief Fincl Officer Effective July 23 >STIM - Moomoo
Greenbrook Gets New General Manager; Legal Head to Step Down Aug. 15 - Stock Titan
Neuronetics: A High-Stakes Turnaround Play with 143% Upside Potential - Kavout | AI
Why Is Neuronetics Stock Soaring Monday? - Benzinga
BTIG initiates Neuronetics stock with buy rating on mental health platform - Investing.com UK
STIM Initiated Coverage by BTIG -- Price Target Set at $5.00 - GuruFocus
BTIG initiates Neuronetics stock with buy rating on mental health platform By Investing.com - Investing.com South Africa
Neuronetics Price Target Announced at $5.00/Share by BTIG - Moomoo
Frontier tech research, news & data - MLQ.ai
Neuronetics Inc. STIM Slides As Weak Margins Pressure Stock - StocksToTrade
Neuronetics Inc. Stock Dips As Traders Weigh Losses And Cash Burn - timothysykes.com
Neuronetics: Top Line Growth, Low Valuation, But Gross Margin Struggles (NASDAQ:STIM) - Seeking Alpha
Neuronetics (STIM) Slips 8.6% as Bearish Pressure Intensifies – Key Support in FocusSchiff Line - dars.gov.et
Neuronetics Could Double, But The Balance Sheet May Crack First (NASDAQ:STIM) - Seeking Alpha
Q3 2025 Neuronetics Inc Earnings Call Transcript - GuruFocus
Neuronetics Inc. (STIM) Q1 2026 Earnings: EPS Beats Estimates, Shares Rise Despite Sparse Revenue DisclosureDiluted EPS Report - dars.gov.et
Finanzdaten der Neuronetics Inc-Aktie (STIM)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.04%
11.95%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):